List of Excipients in API bortezomib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing bortezomib
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Hospira Inc | BORTEZOMIB | bortezomib | 0409-1703 | MANNITOL | |
Takeda Pharmaceuticals America Inc | VELCADE | bortezomib | 63020-049 | MANNITOL | |
Fresenius Kabi USA LLC | BORTEZOMIB | bortezomib | 63323-721 | BORIC ACID | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing bortezomib
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Hikma Pharmaceuticals USA Inc | bortezomib | 0143-9098 | MANNITOL |
Hospira Inc | bortezomib | 0409-1700 | MANNITOL |
Baxter Healthcare Corporation | bortezomib | 10019-991 | MANNITOL |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for bortezomib
Excipient focus: BORIC ACID
bortezomib drug variants containing BORIC ACID
Company | Ingredient | NDC |
---|---|---|
Fresenius Kabi USA LLC | bortezomib | 63323-721 |
>Company | >Ingredient | >NDC |
bortezomib drug variants not containing BORIC ACID
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bortezomib | 0143-9098 |
Hospira Inc | bortezomib | 0409-1700 |
Hospira Inc | bortezomib | 0409-1703 |
>Company | >Ingredient | >NDC |
Excipient focus: DIMETHYL SULFOXIDE
bortezomib drug variants containing DIMETHYL SULFOXIDE
Company | Ingredient | NDC |
---|---|---|
MAIA Pharmaceuticals Inc | bortezomib | 70511-161 |
FOSUN PHARMA USA INC | bortezomib | 72266-243 |
>Company | >Ingredient | >NDC |
bortezomib drug variants not containing DIMETHYL SULFOXIDE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bortezomib | 0143-9098 |
Hospira Inc | bortezomib | 0409-1700 |
Hospira Inc | bortezomib | 0409-1703 |
>Company | >Ingredient | >NDC |
Excipient focus: GLYCINE
bortezomib drug variants containing GLYCINE
Company | Ingredient | NDC |
---|---|---|
Fresenius Kabi USA LLC | bortezomib | 63323-721 |
>Company | >Ingredient | >NDC |
bortezomib drug variants not containing GLYCINE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bortezomib | 0143-9098 |
Hospira Inc | bortezomib | 0409-1700 |
Hospira Inc | bortezomib | 0409-1703 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
bortezomib drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
MAIA Pharmaceuticals Inc | bortezomib | 70511-161 |
FOSUN PHARMA USA INC | bortezomib | 72266-243 |
>Company | >Ingredient | >NDC |
bortezomib drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bortezomib | 0143-9098 |
Hospira Inc | bortezomib | 0409-1700 |
Hospira Inc | bortezomib | 0409-1703 |
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
bortezomib drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bortezomib | 0143-9098 |
Hospira Inc | bortezomib | 0409-1700 |
Hospira Inc | bortezomib | 0409-1703 |
>Company | >Ingredient | >NDC |
bortezomib drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Fresenius Kabi USA LLC | bortezomib | 63323-721 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE
bortezomib drug variants containing SODIUM ACETATE
Company | Ingredient | NDC |
---|---|---|
MAIA Pharmaceuticals Inc | bortezomib | 70511-161 |
FOSUN PHARMA USA INC | bortezomib | 72266-243 |
>Company | >Ingredient | >NDC |
bortezomib drug variants not containing SODIUM ACETATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bortezomib | 0143-9098 |
Hospira Inc | bortezomib | 0409-1700 |
Hospira Inc | bortezomib | 0409-1703 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
bortezomib drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
MAIA Pharmaceuticals Inc | bortezomib | 70511-161 |
FOSUN PHARMA USA INC | bortezomib | 72266-243 |
>Company | >Ingredient | >NDC |
bortezomib drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | bortezomib | 0143-9098 |
Hospira Inc | bortezomib | 0409-1700 |
Hospira Inc | bortezomib | 0409-1703 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.